(Q51093489)

English

New consensus guidelines from the Clinical and Laboratory Standards Institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria.

scientific article published on 7 December 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/17173232

New consensus guidelines from the Clinical and Laboratory Standards Institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria. (English)

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/17173232

author name string

James H Jorgensen

1

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/17173232

Janet F Hindler

2

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/17173232

language of work or name

0 references

publication date

7 December 2006

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/17173232

Clinical Infectious Diseases

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/17173232

44

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/17173232

2

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/17173232

280-286

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/17173232

Granulicatella and Abiotrophia species from human clinical specimens

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

Infective endocarditis caused by HACEK microorganisms

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

Aeromonas infections and their treatment.

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

Comparative in vitro activities of new quinolones against coryneform bacteria

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

Aureobacterium resistens sp. nov., exhibiting vancomycin resistance and teicoplanin susceptibility

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

Antimicrobial chemotherapy of human infection due to Listeria monocytogenes.

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

Antimicrobial activities against 84 Listeria monocytogenes isolates from patients with systemic listeriosis at a comprehensive cancer center (1955-1997).

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

In vitro susceptibility of Bacillus spp. to selected antimicrobial agents

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

Lactobacillus bacteremia and endocarditis: review of 45 cases

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

In vitro activities of daptomycin and other antimicrobial agents against vancomycin-resistant gram-positive bacteria

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

A case of Leuconostoc ventriculitis with resistance to carbapenem antibiotics

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

Nutritionally variant streptococci

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Abiotrophia isolates

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

The Aeromonas metallo-beta-lactamases: genetics, enzymology, and contribution to drug resistance

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

Beta-lactam resistance in Aeromonas spp. caused by inducible beta-lactamases active against penicillins, cephalosporins, and carbapenems

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

beta-Lactam-susceptibility patterns of Plesiomonas shigelloides strains: importance of inoculum and medium

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

Determination of the antimicrobial activity of 29 clinically important compounds tested against fastidious HACEK group organisms

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

In vitro activities of a new des-fluoroquinolone, BMS 284756, and seven other antimicrobial agents against 151 isolates of Eikenella corrodens

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

Lung abscess due to beta-lactamase-producing Pasteurella multocida

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

In vitro activities of garenoxacin (BMS-284756) against 170 clinical isolates of nine Pasteurella species

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

Broth microdilution and disk diffusion tests for susceptibility testing of Pasteurella species isolated from human clinical specimens

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

Ciprofloxacin- and azithromycin-resistant Campylobacter causing traveler's diarrhea in U.S. troops deployed to Thailand in 1994.

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

Increasing fluoroquinolone resistance in Campylobacter jejuni, Pennsylvania, USA,1982-2001.

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

In vitro activities of 39 antimicrobial agents for Branhamella catarrhalis and comparison of results with different quantitative susceptibility test methods

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: the Alexander Project

1 reference

https://api.crossref.org/works/10.1086%2F510431

21 January 2018

Identifiers

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/17173232

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/17173232

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51093489&oldid=1228594443"